Ladja, Sitti Mira .
HRN: 18-94-61 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/07/2023
CEFUROXIME 750MG (VIAL)
10/07/2023
10/13/2023
IVT
350mg
Q8hrs
Uti
Waiting Final Action
10/09/2023
GENTAMICIN 40MG/ML, 2ML (AMP)
10/09/2023
10/15/2023
IV
60mg
OD
PCAP
Waiting Final Action